8-K: Hagerty Prices Upsized Secondary Offering

Hagerty, Inc. announced the pricing of an upsized secondary offering of 10,000,000 shares of Class A Common Stock, with an option for underwriters to purchase an additional 1,500,000 shares.

Summary

• Hagerty, Inc. has priced an upsized secondary offering of 10,000,000 shares of its Class A Common Stock.
• The selling stockholder, Hagerty Holding Corp. (HHC), also granted underwriters a 30-day option to purchase up to an additional 1,500,000 shares.
• The offering was priced at $14.85 per share.
• The offering is expected to close on or about November 12, 2026.
• Hagerty, Inc. will not receive any proceeds from this sale; the proceeds will go to the selling stockholder.
• The net proceeds to the selling stockholder will be used to redeem a corresponding number of its HHC shares for the benefit of the Kim Hagerty Revocable Trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, indicating active capital management and shareholder benefit, though it's a secondary offering with no direct capital infusion for the company.

Positives

• The secondary offering was upsized, indicating strong demand from investors for Hagerty's Class A Common Stock.
• The offering price of $14.85 per share provides a clear valuation benchmark.
• The use of proceeds by the selling stockholder to redeem shares for the benefit of the Kim Hagerty Revocable Trust suggests a strategic move for shareholder value or internal restructuring.
• The involvement of major underwriters like J.P. Morgan and Wells Fargo Securities signifies confidence in the offering.

Negatives

• Hagerty, Inc. will not receive any proceeds from this offering, meaning it does not provide direct capital for company operations or growth initiatives.
• The sale is by a selling stockholder, which could be interpreted as existing shareholders looking to divest, though the stated use of proceeds mitigates this concern.

Risks

• The company faces risks related to competition, maintaining strategic relationships, preventing fraud, and managing technology platforms.
• There are risks associated with accelerating adoption of new products and services, and successfully implementing new insurance programs.
• The fronting arrangement with Markel Group Inc. introduces increased exposure to underwriting volatility, catastrophes, reinsurance counterparty risk, and legal/regulatory risks.
• Underwriting and pricing new products, executing sales strategies for Broad Arrow Group, and completing acquisitions on expected terms are also identified risks.
• The company must manage the cyclical nature of the insurance business, macroeconomic conditions like inflation and interest rates, and potential recessionary pressures.
• Achieving investment objectives and avoiding losses in the investment portfolio are critical.
• Unexpected increases in claim frequency or severity, including catastrophe losses, pose a significant risk.
• Compliance with numerous laws and regulations across various jurisdictions is an ongoing challenge.

Future Outlook

The filing contains forward-looking statements related to the satisfaction of closing conditions, the closing of the offering, and the underwriters' option to purchase additional shares. Actual results could differ materially and adversely from those anticipated.

Management Comments

• Hagerty announced the pricing of its secondary offering, upsized to 10,000,000 shares of Class A Common Stock.
• The Selling Stockholder granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares.
• Hagerty will not receive any proceeds from the sale; the Selling Stockholder will bear underwriting discounts and commissions.
• The net proceeds from the sale will be used by HHC to effect a redemption, for the benefit of the Kim Hagerty Revocable Trust, of a corresponding number of its HHC shares.

Industry Context

StockSavvy.ai notes that secondary offerings, especially when upsized, can signal investor confidence in a company's stock. However, the fact that the proceeds do not go to the company itself means this is more about liquidity for existing shareholders or strategic internal financial maneuvers rather than a capital raise for expansion.

Related Party Transactions

• The net proceeds from the sale of shares by Hagerty Holding Corp. (HHC) will be used to redeem HHC shares for the benefit of the Kim Hagerty Revocable Trust.

Stakeholder Impact

• Shareholders of Hagerty, Inc. may see increased liquidity for Class A Common Stock.
• The Kim Hagerty Revocable Trust will benefit from the redemption of HHC shares.
• Underwriters and investors participating in the offering are directly involved in the transaction.

Next Steps

• The offering is expected to close on or about November 12, 2026.
• The selling stockholder will use net proceeds to redeem HHC shares for the benefit of the Kim Hagerty Revocable Trust.

Key Dates

Recommendation

This filing details a secondary offering where proceeds go to a selling stockholder, not the company. While the upsized offering and clear pricing suggest market interest, it does not provide new capital for Hagerty's growth. The company's inherent risks and the nature of this transaction warrant a 'hold' recommendation pending further operational or strategic developments.

Keywords

secondary offering, Class A common stock, underwriting agreement, stock sale, capital markets, shareholder benefit, insurance, driving enthusiast